KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesOther Gross PP&E AdjustmentsShares Issued
Ratios

Nektar Therapeutics (NKTR) Amortization - Goodwill (2023)

Historic Amortization - Goodwill for Nektar Therapeutics (NKTR) over the last 1 years, with Q1 2023 value amounting to $76.5 million.

  • Nektar Therapeutics' Amortization - Goodwill changed N/A to $76.5 million in Q1 2023 from the same period last year, while for Dec 2023 it was $76.5 million, marking a year-over-year change of. This contributed to the annual value of $76.5 million for FY2023, which is N/A changed from last year.
  • As of Q1 2023, Nektar Therapeutics' Amortization - Goodwill stood at $76.5 million.
  • Nektar Therapeutics' 5-year Amortization - Goodwill high stood at $76.5 million for Q1 2023, and its period low was $76.5 million during Q1 2023.